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Abstract By searching the EST database with the known
cDNA sequence encoding K-caveolin-1 (full-length: FL), we
found a variant having a hitherto unknown sequence in place of
the first exon (5P-end variant: 5PV). The expression level of 5PV
mRNA was equivalent to that of FL mRNA. The entire
sequences of FL and 5PV mRNA were determined by 3P- and
5P-RACE analysis; their sizes were 2484 bp and 2533 bp,
respectively, and the sequences were identical except for the
region of the first exon. By Northern blotting, FL and 5PV
mRNAs showed the same tissue distribution, and were intensely
expressed in the lung, heart, and skeletal muscle. Analyzing the
protein production from these mRNAs using green fluorescent
protein as a tag, we found FL mRNA to produce the K-isoform
predominantly, but to form little L-isoform. The production of
the L-isoform from 5PV mRNA was also demonstrated. By
sequence analysis of the first intron of the caveolin-1 gene, a
TATA box was found at 28 bp upstream of the transcription
initiation site for 5PV mRNA. This is the first demonstration of
caveolin-1 mRNA variants generated by alternative transcription
initiation, and it indicates that the two isoforms of caveolin-1 are
produced from two distinct mRNAs.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Caveolae are invaginations of the plasma membrane and
are seen abundantly in adipocytes, endothelial cells, smooth
muscle cells, and type I pneumocytes. These structures are
believed to play a role in transcytosis of macromolecules [1],
and recent studies have revealed that they are also involved in
cholesterol homeostasis, intracellular signaling, and cell trans-
formation [2^5]. Caveolin-1 was identi¢ed as a major compo-
nent of caveolae [6], and was demonstrated to have many
functions such as cholesterol binding and transport [7,8], in-
hibitory interaction with signaling molecules [9], and suppres-
sion of oncogenic transformation [10]. Moreover, de novo
formation of caveolae was induced by the exogenous expres-
sion of caveolin-1 [11]. These ¢ndings indicate the important
roles of caveolin-1 for caveolar function and formation.
There are two isoforms of caveolin-1, termed K and L. They
are identical except for the additional 31 amino acids of the K-
isoform at its N-terminus, and were shown to be produced by
alternative translation initiation [12]. As to these isoforms, the
di¡erential distribution of these isoforms [12], as well as the
speci¢c phosphorylation of the K-isoform in v-Src trans-
formed cells [13,14] and that of the L-isoform by insulin treat-
ment of 3T3-L1 cells [15], has been reported. However, it is
not clear whether the isoforms have distinct roles in cell func-
tions, or how the expression of both isoforms is regulated.
In the present study, we identi¢ed several mRNA variants
of caveolin-1 by sequence database analysis and 5P- and 3P-
RACE. In particular, a variant lacking the ¢rst exon (5P-end
variant: 5PV) was shown to be generated by alternative tran-
scription initiation, and to be expressed at a level comparable
to that of the mRNA having the ¢rst exon (full-length: FL).
The analysis of protein production from both FL and 5PV
cDNAs revealed that caveolin-1 isoforms are generated from
distinct mRNAs in vivo. A possible promoter region for the
5PV mRNA transcription was also identi¢ed within the ¢rst
intron of the mouse caveolin-1 gene. These data provide a
molecular basis for the regulatory mechanism of the expres-
sion of caveolin-1 isoforms.
2. Materials and methods
2.1. Cell culture
Pam212 cells [16] were kindly provided by Dr. Koji Hashimoto
(Ehime University, Japan). 3Y1 cells [17] were obtained from Ki-
mura’s 3Y1 library at RIKEN Cell Bank (Tsukuba, Japan). Neuro2a
and COS7 cells were obtained from the Japanese Cancer Resources
Research Bank (Tokyo, Japan). Cells were grown at 37‡C in 5% CO2
in Dulbecco’s modi¢ed Eagles minimum essential medium (Nihon-
seiyaku Co.) supplemented with 10% fetal bovine serum, 50 U/ml
penicillin, and 0.05 mg/ml streptomycin.
2.2. RNA and DNA extraction
Total RNA and genomic DNA of culture cells and of BALB/c
mouse tissues were extracted by TRIZOL reagent (Life Technologies,
Inc.). The amounts of RNA and DNA were estimated by OD260. The
OD260=280 ratio of the total RNA was 1.7^1.8 for all of the samples.
2.3. Primers
The sequences of primers used were as follows, with primers having
the /F designation being sense primers and those with /R being anti-
sense primers. Primers for FL caveolin-1: ex1/F 5P-AAATCA-
CAGCCCAGGGAAACC-3P ; a-start/F 5P-ACGATGTCTGGGG-
GCAAATAC-3P ; b-start/F 5P-CAAGGCCATGGCAGACGAG-3P ;
ex1/R 5P-GATGTCCCTCGGAGTCCACG-3P ; ex2/R 5P-CTTGA-
CCACGTCGTCGTTGAG-3P ; stop/R 5P-TCATATCTCTTTCTG-
CGTGCTGAT-3P. Primers for 5PV: 5PV/F1 5P-TAGCAAAAGTTG-
TAGCGCCAG-3P ; 5PV/F2 5P-CTTTTCTTCCCACCGCTGTTGC-
3P ; intl/R 5P-GTAGAGATGTCCCTGTGAGG-3P. 5PV/F1 and 5PV/
F2 were generated according to the expressed sequence tag (EST)
sequences AA655345, AA726617 and AA726618. Primers for RACE
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[18]: double adapter-oligo dT (DA-dT) 5P-AAGGATCCGAATCGC-
TAGCTAATACGACTCACTATAGGGATTTTTTTTTTTTTTTT-
TTTT-3P ; outer primer (Po) 5P-AAGGATCCGAATCGC-3P ; inner
primer (Pi) 5P-CGCTAGCTAATACGACTCAC-3P. The locations of
caveolin-1-speci¢c primers are shown in Fig. 1A.
2.4. Polymerase chain reaction (PCR)
For RT-PCR, total RNA was reverse-transcribed by SuperScript1
II reverse transcriptase (Life Technologies, Inc.) with random hexam-
er primers, and ampli¢ed with the following primer sets: a-start/F and
ex2/R or stop/R for FL; 5PV/F1 or 5PV/F2 and ex2/R or stop/R for
5PV. For 3P-RACE, total RNA was reverse-transcribed by AMV re-
verse transcriptase XL (Takara Shuzo Co., Ltd.) or SuperScript1 II
reverse transcriptase with DA-dT primer and ampli¢ed by LA Taq1
DNA polymerase (Takara Shuzo Co., Ltd.) with primers Po and a-
start/F for FL, or Po and 5PV/F1 for 5PV. The PCR products were
further ampli¢ed with nested primers Pi and b-start/F for FL, or with
Pi and 5PV/F2 for 5PV. For 5P-RACE, total RNA was reverse-tran-
scribed with stop/R, poly(A) was added to the end of the ¢rst-strand
cDNA, and PCR was performed with primers DA-dT and ex2/R as
the ¢rst round of ampli¢cation. In the second-round PCR, Pi and ex1/
R for FL, or Pi and int1/R for 5PV were used. To obtain the DNA
fragment of the ¢rst intron of the mouse caveolin-1 gene, we ampli¢ed
mouse genomic DNA with primers a-start/F and int1/R.
2.5. Sequence analysis
All PCR products were sequenced directly or after subcloning in
pT7Blue-T vector (Novagen). The database sequence search was per-
formed using BLAST 2.0 (http://www.ncbi.nlm.nih.gov/). Assembly
and analysis of the sequences were achieved with a DNASTAR soft-
ware package (DNASTAR Inc). The alignment of multiple sequences
was performed with Clustal W [19]. The prediction of promoter sites
and transcription factor binding sites was performed with the Pro-
moter Prediction by Neural Network (NNPP) program [20] and
with Transcription Element Search Software (TESS) using the
TRANSFAC database [21] (http://www.hgsc.bcm.tmc.edu/).
2.6. Northern blotting
The expression of mRNA variants of caveolin-1 was examined by
Northern blotting using Mouse Multiple Tissue Northern Blot (Clon-
tech). The cDNA probes were generated by PCR using the following
primers: a-start/F and stop/R for ORF (common: 537 bp); 5PV/F1
and int1/R for 5PV (140 bp); and ex1/F and ex1/R for FL (117 bp).
The positions of the probes are presented in Fig. 2. The probe for L-
actin supplied by Clontech was used as a control. The probes were
labeled with [K-32P]dCTP, and the hybridization was carried out for
3 h in ExpressHyb1 solution (Clontech) at 65‡C for FL or at 68‡C
for other probes. Signals were visualized by exposing the blots to
X-ray ¢lm for 2^6 days.
2.7. Protein expression from FL and 5PV caveolin-1 mRNA
The cDNA construct encoding the chimeric protein of K-caveolin-1
and green £uorescent protein (GFP) having no 5P untranslated region
(UTR) sequence (FL1) was produced previously [22]. The cDNAs
corresponding to the bp 59^614 sequence of FL cDNA (FL2: with
22 bp of 5PUTR) and bp 31^663 of 5PV cDNA (5PV: with 191 bp of
5PUTR) were subcloned into pEGFP-N1 (Clontech) for the expression
of the chimeric proteins. COS7 and 3Y1 cells were transiently trans-
fected with the cDNA constructs with SuperFect (Qiagen). For West-
ern blot analysis, the transfected COS7 cells were dissolved in an SDS
sample bu¡er; and the proteins were separated by SDS-PAGE and
transferred onto a nitrocellulose membrane. The blotted membranes
were probed with mouse monoclonal anti-caveolin-1 antibody (C060,
Transduction Laboratories) or rabbit polyclonal anti-GFP antibody
(Clontech), and the signal was detected with a SuperSignal Chemilu-
minescent System (Pierce). For £uorescence microscopy, the transi-
ently transfected 3Y1 cells were ¢xed with 3% formaldehyde for
5 min, and the images were captured by a chilled CCD camera (Ha-
mamatsu Photonics) with the operating program IPLab Spectrum
(Signal Analytics).
3. Results and discussion
By the database sequence search, a cDNA sequence of cav-
eolin-1 lacking the ¢rst exon (5PV) was found to be registered
in mouse and human EST databases (for example, AA655345
in mouse and AA376123 in human). It contained a hitherto
unknown sequence in place of the ¢rst exon of FL caveolin-1
mRNA. The expression of FL and 5PV mRNA was detected
by RT-PCR in Pam212 cells, but not in Neuro2a cells (Fig.
1B). The approximate expression levels of FL and 5PV were
estimated by RT-PCR using a common antisense primer
(stop/R or ex2/R) and a mixture of two sense primers speci¢c
to FL (a-start/F) and 5PV (5PV/F1). As a common primer is
assumed to prime to both cDNAs with the same e⁄ciency, the
amount of the products should re£ect the ratio of FL and 5PV
mRNAs expressed in cells. RT-PCR products from both FL
Fig. 1. RT-PCR, 3P-RACE, and 5P-RACE analyses of mouse caveo-
lin-1 mRNA variants. A: Schematic representation of mouse caveo-
lin-1 mRNA variants FL and 5PV, and primer sites used for the
ampli¢cation. Shadowed boxes indicate the coding region for K-cav-
eolin-1 in FL and L-caveolin-1 in 5PV, respectively. The vertical bro-
ken lines indicate the splicing sites of exons. B: RT-PCR ampli¢ca-
tion of mouse caveolin-1 mRNAs, FL (primer set: a-start/F and
stop/R) and 5PV (primer set: 5PV/F2 and stop/R). The expected size
of the products was 551 bp and 574 bp, respectively. Both products
were detected in Pam212 cells (P) but not in Neuro2a cells (N). C:
RT-PCR ampli¢cation of mouse caveolin-1 mRNAs by use of a
common antisense primer stop/R (lane A) or ex2/R (lane B) and a
mixture of two sense primers, a-start/F and 5PV/F1. The result
shows the comparable expression of both FL and 5PV mRNA in
Pam212 cells. The expected sizes of the PCR products are 646 and
551 bp in lane A, and 293 and 198 bp in lane B for FL and 5PV
mRNA, respectively. D: 3P-RACE of FL and 5PV mRNA. Primer
sets used for the ampli¢cation were as follows: FL 1st: a-start/F
and Po; FL 2nd: b-start/F and Pi; 5PV 1st: 5PV/F1 and Po; 5PV
2nd: 5PV/F2 and Pi. PCR products of approximately 2.5 kb and
1.9 kb were obtained for both FL and 5PV. E: 5P-RACE of FL and
5PV mRNA. In the ¢rst round of PCR, DA-dT and ex2/R were
used as primers. In the second round, the ampli¢cation was per-
formed with a combination of a common primer Po and a primer
speci¢c for FL (ex1/R) or for 5PV (int1/R). The obtained DNA frag-
ment was approximately 210 bp for FL and 240 bp for 5PV.
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and 5PV mRNAs were detected as bands of similar intensity
(Fig. 1C).
As ESTs contain only partial sequences, it was unclear
whether FL and 5PV mRNA have any other di¡erence in their
overall sequences. The molecular cloning of the mammalian
caveolin-1 gene has been accomplished for human (Z18951),
mouse (U07645), rat (Z46614), dog (Z12161), and cattle
(U86639) genes. However, the sequences are limited to those
just around the coding region; and thus a large part of the
mRNAs, whose size was approximately 2.5^3.0 kb by North-
ern blotting of mouse [15] and human [23] samples, has not
been identi¢ed yet. For the identi¢cation of the entire sequen-
ces of FL and 5PV mRNA, we performed 3P- and 5P-RACE.
As 3P-RACE products, when reverse-transcribed with AMV
reverse transcriptase XL, major (2.5 kb) and minor (1.9 kb)
products were obtained from both FL and 5PV mRNA (Fig.
1D, arrows). Sequencing revealed that the products from both
FL and 5PV were identical in sequence except for the 5P-end
region. The 2.5-kb product had the 1867 bp of 3PUTR se-
quence with a putative polyadenylation signal AATAAA at
position 2465 in AB029929. The 1.9-kb product was revealed
to be an alternative splicing variant of the 2.5-kb species with
a deletion of 620 bp in the 3PUTR (bp 639^1258 in AB029929)
having the GT-AG intron character. In the samples reverse-
transcribed with SuperScript II, additional bands of 1.4 kb
and 0.8 kb were detected in both mRNAs (data not shown);
they were alternatively polyadenylated at 1372 and at 774,
respectively. Taken together, FL and 5PV mRNA share the
common sequence in the downstream region of the second
exon, and show heterogeneity of their 3PUTR, which is caused
by alternative splicing and polyadenylation. As to the 3PUTR
of human caveolin-1 mRNAs, the corresponding splice var-
iants are not expressed; but instead, a 0.8-kb mRNA gener-
ated by early polyadenylation was registered in the EST data-
base and also detected by Northern blotting [23]. In recent
studies, the involvement of the 3PUTR sequences in the intra-
cellular localization, stability, and translational regulation of
mRNA has been suggested [24] ; however, the signi¢cance of
the 3PUTR heterogeneity in caveolin-1 mRNA has not been
determined yet.
As 5P-RACE products, bands with an approximate size of
210 bp for FL and 240 bp for 5PV were obtained (Fig. 1E,
lanes FL and 5PV, respectively). By the sequence analysis,
products containing 80, 73, 60 and 48 bp of 5PUTR sequence
were obtained from FL. On the other hand, the products from
5PV contained 158 bp of the upstream sequence from the 5P-
end of the second exon, and the sequence revealed that the
5PV mRNA putatively encodes the L-isoform of caveolin-1
and has 221 bp of 5PUTR sequence. The success of the primer
extension to the end was con¢rmed by the fact that an addi-
tional G was detected at the end of all of the 5P-RACE prod-
ucts, indicating the reverse transcription of the capping gua-
nine nucleotide. While our study was in progress, the sequence
speci¢c to 5PV was reported to be the intron sequence of the
caveolin-1 gene [25], and we con¢rmed it by genomic PCR
ampli¢cation (data not shown). Taken together, we identi¢ed
the full sequence of FL and 5PV caveolin-1 mRNA, and the
sequence was con¢rmed by referencing many mouse EST se-
quences; they were available from Genbank/EMBL/DDBJ
under accession number AB029929 for FL (2484 bp) and
AB029930 for 5PV (2533 bp) cDNA. The gene and cDNA
structure of mouse caveolin-1 are schematically presented in
Fig. 2.
The tissue distribution of both mRNAs was examined by
Northern blotting (Fig. 3). Using a common probe, ORF, we
detected caveolin-1 mRNAs as major (2.7 kb) and minor (2.1
kb) bands intensely expressed in the lung, skeletal muscle, and
heart, and weakly in the kidney, testis, brain, and spleen (in
decreasing order), but not in the liver. The sizes of the
mRNAs were consistent with the sequences of FL and 5PV
mRNA, and the lower minor band was considered to corre-
spond to the alternative splicing variant having the 620-bp
deletion in the 3PUTR region. Northern blotting with the
speci¢c probes for 5PV (140 bp) and FL (117 bp) was also
performed. The tissue distribution as well as the apparent
sizes of the two mRNAs were the same (Fig. 3, FL and
5PV), although the speci¢c probe for FL mRNA did not gen-
erate intense signals, probably due to the shortness of the
probe. Although the existence of the splicing variant was
not shown for FL mRNA in Northern blotting, the 620-bp
deletion in the 3PUTR was equally detected in both FL and
5PV mRNAs by RT-PCR (data not shown). Although the
tissue distribution was apparently the same for the two
mRNAs, there remains a possibility that the mRNAs are dif-
ferentially regulated, or that their expression ratio is diverse
among di¡erent cell types. Previous studies showed that cav-
eolin-1 gene expression is modulated by cell transformation
with activated mitogen-activated protein kinase signaling [26],
cellular free cholesterol [27,28], and cyclic AMP signals [29].
However, unfortunately, because the probes used in the ex-
Fig. 2. Schematic representation of mouse FL and 5PV caveolin-1 mRNAs with the gene structure. The nucleotide sequence data of FL and
5PV mRNAs will appear in the nucleotide sequence database DDBJ/EMBL/GenBank with the accession numbers AB029929 and AB029930, re-
spectively. The gene structure of mouse caveolin-1 was demonstrated by Engelman et al. [25]. Shadowed boxes indicate the coding region for
K-caveolin-1 in FL and for L-caveolin-1 in 5PV. The vertical broken lines indicate the splicing sites. The vertical dotted lines within the third
exon indicate the alternative splicing sites causing the 620-bp deletion. The regions of cDNA fragments used as probes for Northern blotting
are also indicated with solid bars (ORF for pan caveolin-1 mRNA: FL for FL mRNA; 5PV for 5PV mRNA).
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periments recognize both FL and 5PV mRNA, and the sizes of
the two mRNAs are apparently the same, no information is
available concerning the di¡erential regulation of these two
mRNAs. At the protein level, for example, regulation appar-
ently speci¢c to the K-isoform has been suggested in cell cycle
progression [30]. Examination of whether FL and 5PV
mRNAs are di¡erentially regulated, leading to the production
of the protein isoforms in di¡erent ratios, may provide a clue
to elucidate the physiological roles of these isoforms.
The two isoforms of caveolin-1, K and L, have been believed
to be produced by alternative translation initiation from a
single mRNA [12], but the molecular mechanism that regu-
lates the expression of the two isoforms has been unknown.
The protein production from the caveolin-1 mRNA variants
was examined by the transient expression of GFP chimeras in
COS7 cells (Fig. 4A). As reported previously [12], both K- and
L-caveolin-1/GFP were produced by transfection with the
cDNA construct having no 5PUTR sequence (Fig. 4A, FL1).
However, the construct having 22 bp of the 5PUTR sequence
including the Kozak sequence gave rise to preferentially the K-
caveolin-1/GFP with little L-isoform (Fig. 4A, FL2), suggest-
ing that FL caveolin-1 mRNA dominantly generates the K-
isoform in vivo. The e⁄cient production of the L-isoform
from 5PV mRNA was also con¢rmed (Fig. 4A, 5PV). The
present study clearly demonstrates that the two isoforms are
most likely generated by the translation of the two distinct
mRNAs, FL and 5PV, rather than by alternative translation
initiation of FL mRNA, indicating that the regulatory mech-
anism for the isoform expression may be ascribed to the tran-
scriptional regulation of FL and 5PV mRNAs. However, this
result does not exclude the possible contribution of an alter-
native translation initiation mechanism to isoform production
in vivo. Further studies are necessary to clarify the precise
mechanism regulating the relative ratio of the two isoforms.
The cellular localization of the two isoforms was observed by
£uorescence microscopy; both K- and L-caveolin-1/GFP were
seen to exist in cell edges, and the localization was indistin-
guishable from each other in 3Y1 (Fig. 4B) and COS7 cells
(data not shown).
To analyze the structure of the promoter for the 5PV
mRNA transcription, we obtained the genomic sequence of
the ¢rst intron of the mouse caveolin-1 gene by PCR and
sequenced it (accession number AB029931). It contained the
whole 5P-end sequence of 5PV mRNA, and the NNPP pro-
gram also predicted the transcription start from this position.
The partial sequence of the ¢rst intron is compared with that
of the human gene [31] in Fig. 5. A putative TATA box was
found at 328 from the transcription initiation site (Fig. 5,
boxed). The upstream sequence from the transcription start
site was highly conserved between human and mice (84%
identity in 31 to 3116), suggesting the critical function of
this region for the transcriptional regulation. In addition,
some putative transcription factor binding sites have been
predicted based on a TRANSFAC database search in this
intron region. For example, the putative binding site for apo-
lipoprotein A1 regulatory protein-1 was found at 3107 bp,
close to the promoter region (Fig. 5, shown by a broken line);
and further upstream, that for sterol regulatory element bind-
ing protein-1 was predicted at 3230 bp. The possible involve-
ment of these transcription factors is consistent with the pu-
tative functions of caveolin-1 in cholesterol homeostasis [2].
The putative sterol-responsive elements upstream of the ¢rst
exon was assumed to be involved in the regulation of caveo-
Fig. 3. Northern blot analysis of mouse caveolin-1 mRNA variants.
The top panel shows the distribution of mouse caveolin-1 mRNA
detected with the ORF probe, which recognizes both FL and 5PV
mRNAs. Two bands, 2.7 kb and 2.1 kb, were detected in highly ex-
pressing tissues such as heart, lung and skeletal muscle. The second
and third panels show the result with 5PV- and FL-speci¢c probes,
respectively. The apparent size and the tissue distribution were iden-
tical for the two mRNAs. The bottom panel is a control blot with
the L-actin probe.
Fig. 4. Analysis of protein production from FL and 5PV mRNA
tagged with GFP. A: Western blot analysis of the chimeric proteins
transiently expressed in COS7 cells. Anti-GFP antibody (anti-GFP)
and anti-caveolin-1 antibody (anti-cav1) were used for the detection.
While both K- and L-caveolin-1/GFP were comparably produced
from the construct having no 5PUTR sequences (FL1), K-caveolin-1/
GFP was predominantly expressed from the construct having 22 bp
of 5PUTR sequence (FL2). L-Caveolin-1/GFP was e⁄ciently pro-
duced from the 5PV/GFP constructs (5PV). B: Fluorescence photo-
graphs of K- and L-caveolin-1/GFP (FL2 and 5PV) in 3Y1 cells. The
distribution of K- and L-caveolin-1/GFP was not distinguishable.
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lin-1 expression by free cholesterol [32]. Our data indicate that
possible transcription regulatory elements are also present
within the ¢rst intron. The analysis of the transcriptional ac-
tivity of the intron region is the next object of our study.
In conclusion, we identi¢ed a novel caveolin-1 mRNA var-
iant lacking the ¢rst exon, and demonstrated that the K and L
isoforms of caveolin-1 are generated by the translation of
distinct mRNAs, indicating that the expression of the caveo-
lin-1 isoforms is regulated at the transcriptional level. Further
analysis of the regulation of caveolin-1 gene expression should
lead to the clari¢cation of the biological roles of caveolin-1
isoforms in cell functions.
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Fig. 5. Promoter structure of an alternative transcription initiation
site for mouse 5PV caveolin-1 mRNA in comparison with the hu-
man sequence. The transcription initiation site determined by 5P-
RACE in mice is indicated as +1. The putative TATA box at 328
is indicated by a box. More upstream, around 390, possible GC
boxes exist. A motif for the putative apolipoporotein A1 regulatory
protein recognition predicted by the TRANSFAC database is under-
lined with a broken line. Identical nucleotides between human and
mouse are indicated by asterisks. The whole sequence of the ¢rst in-
tron of mouse caveolin-1 is available in the DDBJ/EMBL/GenBank
database with the accession number AB029931.
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